IL88159A - Salts of pentamidine and pharmaceutical preparations containing them - Google Patents

Salts of pentamidine and pharmaceutical preparations containing them

Info

Publication number
IL88159A
IL88159A IL8815988A IL8815988A IL88159A IL 88159 A IL88159 A IL 88159A IL 8815988 A IL8815988 A IL 8815988A IL 8815988 A IL8815988 A IL 8815988A IL 88159 A IL88159 A IL 88159A
Authority
IL
Israel
Prior art keywords
pentamidine
salt
acid
formulation
composition
Prior art date
Application number
IL8815988A
Other languages
English (en)
Hebrew (he)
Other versions
IL88159A0 (en
Original Assignee
Fujisawa U S A Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa U S A Inc filed Critical Fujisawa U S A Inc
Publication of IL88159A0 publication Critical patent/IL88159A0/xx
Publication of IL88159A publication Critical patent/IL88159A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/08—Acetic acid
    • C07C53/10—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08—Lactic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL8815988A 1987-11-06 1988-10-25 Salts of pentamidine and pharmaceutical preparations containing them IL88159A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11828487A 1987-11-06 1987-11-06

Publications (2)

Publication Number Publication Date
IL88159A0 IL88159A0 (en) 1989-06-30
IL88159A true IL88159A (en) 1994-04-12

Family

ID=22377637

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8815988A IL88159A (en) 1987-11-06 1988-10-25 Salts of pentamidine and pharmaceutical preparations containing them

Country Status (14)

Country Link
EP (1) EP0315467A3 (fr)
JP (1) JPH02150A (fr)
KR (1) KR970008156B1 (fr)
CN (1) CN1020897C (fr)
AU (1) AU618762B2 (fr)
BR (1) BR8805759A (fr)
CA (1) CA1336003C (fr)
DK (1) DK616088A (fr)
FI (1) FI885020A (fr)
GR (1) GR1000263B (fr)
IL (1) IL88159A (fr)
IN (1) IN168530B (fr)
MX (1) MX13665A (fr)
NO (1) NO171723C (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE77947T1 (de) * 1987-04-09 1992-07-15 Fisons Plc Pentamidin enthaltende pharmazeutische zusammensetzungen.
US5364615A (en) * 1987-12-23 1994-11-15 Regents Of The University Of California Prophylaxis of pneumocystis carinii with aerosilized pentamidine
US5366726A (en) * 1987-12-23 1994-11-22 The Regents Of The University Of California Suppression of Pneumocystis carinii using aerosolized pentamidine treatment
US5807572A (en) * 1988-02-18 1998-09-15 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
DE3851951T2 (de) * 1988-03-31 1995-02-23 Orbisphere Lab Inc Wilmington Amperometrische Messmethode Amperometrische Messmethode.
GB8903438D0 (en) * 1989-02-15 1989-04-05 May & Baker Ltd New compositions of matter
DE4122744C2 (de) * 1990-08-06 1994-02-03 Nattermann A & Cie Wäßriges Liposomensystem und Verfahren zu seiner Herstellung
DE4108902A1 (de) * 1990-08-06 1992-02-13 Nattermann A & Cie Wasserhaltiges liposomensystem
US5556637A (en) * 1990-08-06 1996-09-17 A. Nattermann & Cie. Gmbh Water containing liposome system
DE4122661C2 (de) * 1990-08-06 1996-07-11 Nattermann A & Cie Pharmazeutisches Produkt zur Behandlung von Pneumocystis-carinii-Pneumonie
US6663885B1 (en) 1993-03-15 2003-12-16 A. Natterman & Cie Gmbh Aqueous liposome system and a method for the preparation of such a liposome system
JP3002702B2 (ja) * 1993-11-16 2000-01-24 スカイファーム インコーポレーテッド 活性物質の制御放出を有する小胞
MX9703653A (es) * 1995-09-19 1998-07-31 Cellular Sciences Inc Composicion y metodo para tratar enfermedades mamiferas ocasionadas por la respuesta inflamatoria.
KR100219601B1 (ko) * 1996-05-15 1999-09-01 윤종용 인쇄면 판별영역을 갖는 ohp 및 승화형 열전사 프린터의 ohp 인쇄면 판별 방법 및 이에 적합한 장치
DE10149919A1 (de) 2001-10-10 2003-04-24 Biosphings Ag Neue Salze von Guanidinderivaten und pharmazeutische Zubereitungen daraus
JP3972876B2 (ja) * 2003-09-03 2007-09-05 日産自動車株式会社 エンジンの燃料カット制御装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410796A (en) * 1942-04-11 1946-11-05 May & Baker Ltd Soluble amidine salts
US2425221A (en) * 1942-07-27 1947-08-05 May & Baker Ltd Production of amidine salts
GB575145A (en) * 1944-02-23 1946-02-05 May & Baker Ltd Improvements in or relating to the preparation of amidine salts
AU620025B2 (en) * 1987-03-26 1992-02-13 Sloan-Kettering Institute For Cancer Research Method of preventing pneumocystis carinii pneumonia using pentamidine in an aerosol form

Also Published As

Publication number Publication date
AU618762B2 (en) 1992-01-09
EP0315467A3 (fr) 1990-09-26
JPH02150A (ja) 1990-01-05
NO884881D0 (no) 1988-11-02
EP0315467A2 (fr) 1989-05-10
NO884881L (no) 1989-05-08
CN1020897C (zh) 1993-05-26
AU2447688A (en) 1989-05-11
DK616088D0 (da) 1988-11-04
IL88159A0 (en) 1989-06-30
MX13665A (es) 1993-12-01
KR890007723A (ko) 1989-07-05
KR970008156B1 (ko) 1997-05-21
BR8805759A (pt) 1989-07-25
NO171723B (no) 1993-01-18
IN168530B (fr) 1991-04-20
FI885020A0 (fi) 1988-11-01
NO171723C (no) 1993-04-28
CA1336003C (fr) 1995-06-20
DK616088A (da) 1989-05-07
FI885020A (fi) 1989-05-07
CN1033046A (zh) 1989-05-24
GR1000263B (el) 1992-05-12

Similar Documents

Publication Publication Date Title
CA1336003C (fr) Sels de pentamidine utiles pour le traitement et la prophylaxie de la pneumonie a pneumocystis carinii
EP0664703B1 (fr) Methodes pour lutter contre la pneumonie (pneumocystis carinii) et composes utiles a cet effet
US4829088A (en) Medicament for the treatment of inflammations of the eye
JP2645427B2 (ja) 混合ミセル溶液
JP4598908B2 (ja) カチオン性リポソームとポリデオキシリボヌクレオチドとの複合体
US7989432B2 (en) Micelles
AU750481B2 (en) Erythropoietin liposomal dispersion
JPH08268893A (ja) スタウロスポリン誘導体の静脈内投与のための医薬組成物
US5283067A (en) Parenteral suspensions
EP1439830B1 (fr) Composition pharmaceutique d'acide propionique 2-(4-isobutylphenyle)
HU186296B (en) Process for producing parenteral pharmaceutical compositions
JPH03181422A (ja) 炎症の治療方法及び炎症の治療用合成薬
US6727286B2 (en) Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
EP0225162B1 (fr) Inhibition de la formation de l'adhérence postchirurgicale par l'administration topique d'un médicament anti-inflammatoire non stéroide
US5084480A (en) Pentamidine salts useful in the treatment of pneumocystis carinii pneumonia
EP0833640B1 (fr) Composition pharmaceutique contenant de la lamotrigine
EP0345926B1 (fr) Compositions pharmaceutiques contenant de la pentamidine
IE60453B1 (en) Parenteral suspensions of diclofenac
US5658950A (en) Therapeutic agent for glaucoma and ocular hypotensive agent
WO2024012556A1 (fr) Composé amino-lipide, son procédé de préparation, composition associée et application associée
HU204700B (en) Process for producing aqueous compositions comprising piperidinyl cyclopentylheptenoic acid derivatives

Legal Events

Date Code Title Description
HP Change in proprietorship
RH Patent void